Merkel cell carcinoma: demographic, clinical, and treatment parameters of prognostic significance

2016 ◽  
Vol 5 (2) ◽  
pp. 205-212
Author(s):  
Michael A. Fu ◽  
Evan C. Osmundson ◽  
Rie von Eyben ◽  
Susan J. Knox ◽  
Daniel S. Kapp
2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Loren Masterson ◽  
Bryan J. Thibodeau ◽  
Laura E. Fortier ◽  
Timothy J. Geddes ◽  
Barbara L. Pruetz ◽  
...  

Due to the rarity of Merkel cell carcinoma (MCC), prospective clinical trials have not been practical. This study aimed to identify biomarkers with prognostic significance. While sixty-two patients were identified who were treated for MCC at our institution, only seventeen patients had adequate formalin-fixed paraffin-embedded archival tissue and followup to be included in the study. Patients were stratified into good, moderate, or poor prognosis. Laser capture microdissection was used to isolate tumor cells for subsequent RNA isolation and gene expression analysis with Affymetrix GeneChip Human Exon 1.0 ST arrays. Among the 191 genes demonstrating significant differential expression between prognostic groups, keratin 20 and neurofilament protein have previously been identified in studies of MCC and were significantly upregulated in tumors from patients with a poor prognosis. Immunohistochemistry further established that keratin 20 was overexpressed in the poor prognosis tumors. In addition, novel genes of interest such as phospholipase A2 group X, kinesin family member 3A, tumor protein D52, mucin 1, andKITwere upregulated in specimens from patients with poor prognosis. Our pilot study identified several gene expression differences which could be used in the future as prognostic biomarkers in MCC patients.


2019 ◽  
Vol 43 (7) ◽  
pp. 907-919 ◽  
Author(s):  
Emily M. Erstine ◽  
Michael T. Tetzlaff ◽  
Xuefei Jia ◽  
Phyu P. Aung ◽  
Victor G. Prieto ◽  
...  

2002 ◽  
Vol 28 (2) ◽  
pp. 113-117
Author(s):  
KHOSROW MEHRANY ◽  
CLARK C. OTLEY ◽  
ROGER H. WEENIG ◽  
P. KIM PHILLIPS ◽  
RANDALL K. ROENIGK ◽  
...  

1988 ◽  
Vol 6 (12) ◽  
pp. 1863-1873 ◽  
Author(s):  
S Pilotti ◽  
F Rilke ◽  
C Bartoli ◽  
A Grisotti

A study of 50 consecutive cases (22 men, 28 women; age range, 39 to 84 years; mean age, 65 years) of cutaneous neuroendocrine Merkel cell carcinoma (CNC), 39 of whom had a mean follow-up of 34 months, revealed that the prognostic significance of the histopathologic subtyping in trabecular, solid, and diffuse variants of CNC was not as important as the pathologic postsurgical staging in localized, regional, and extraregional disease. The overall mortality was 23.5%. None of the 19 patients with localized disease died of CNC, while 11% of the 24 patients with regional disease and all seven patients with extraregional disease at presentation died of CNC. A second primary malignancy was found to be associated with the CNC in 15% of the cases. The clinical course in patients with localized disease was favorable in spite of the high number of local recurrences. Also, the presence of regional metastases was not related to an unfavorable prognosis. In 68% of the cases the disease involved the lower limbs or girdle. In ten cases the overt exophytic presentation of primary CNC was replaced by the presence of tumor masses infiltrating the inguinal soft tissues with or without nodal involvement.


2014 ◽  
Vol 272 (7) ◽  
pp. 1777-1783 ◽  
Author(s):  
Alexandra Fochtmann ◽  
Georg Haymerle ◽  
Rainer Kunstfeld ◽  
Johannes Pammer ◽  
Matthaeus Ch. Grasl ◽  
...  

Author(s):  
Morgan Guénolé ◽  
Paolo Bénigni ◽  
Vincent Bourbonne ◽  
François Lucia ◽  
Delphine Legoupil ◽  
...  

2002 ◽  
Vol 28 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Khosrow Mehrany ◽  
Clark C. Otley ◽  
Roger H. Weenig ◽  
P. Kim Phillips ◽  
Randall K. Roenigk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document